Company: ABUS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001447028-25-000126
Chunk: 19

Company: Arbutus Biopharma Corp
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 6
Chunk 19
---
S

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 13, 2025.

ARBUTUS BIOPHARMA CORPORATION By:/s/ Lindsay Androski  Lindsay Androski  President and Chief Executive Officer(Principal Executive Officer)By:/s/ Tuan NguyenTuan NguyenChief Financial Officer(Principal Financial Officer and Principal Accounting Officer)

41